In the realm of women's health, a silent crisis lurks in the shadows of menopause, a crisis that affects millions yet remains largely unspoken. Vaginal dryness, a symptom that plagues more than half of women during or after menopause, is a prime example of this hidden struggle. What's more, the stigma surrounding this issue often prevents women from seeking help, leaving them to endure in silence. This is where Biolae steps in, a company founded by Maryalice Rosa and the author, with a mission to address this gap in women's health. The company's focus is on providing clinically validated, non-hormonal solutions for perimenopause, a field that has been largely overlooked by innovators.
The author, having sold their first company and gained freedom to pursue meaningful ventures, recognized the need for change in women's health. They observed that while there was a wealth of innovation in fertility and pregnancy, the same couldn't be said for perimenopause and its associated symptoms. This realization led to the creation of Biolae, with a commitment to setting a new standard for clinical validity. The company's Scientific Advisory Board ensures that their products are backed by gold-standard clinical trials, dosed at therapeutic levels, and independently tested for purity and potency.
One of Biolae's most significant milestones is the upcoming launch of Australia's first TGA-listed hyaluronic acid pessary. This product, three years in the making, represents a major step forward in addressing vaginal dryness. The author acknowledges the weight of this responsibility, understanding that launching a first-to-market medical device in a personal category comes with real challenges. They also recognize that vaginal dryness is not solely a menopause symptom but a women's health issue that affects postpartum, stressful seasons, and those on certain medications.
The author's background in consumer brands has been a valuable asset in Biolae's approach. They understand that women connect with brands that understand them, and they aim to prove that design, experience, and community can be prioritized alongside efficacy. The company's campaign, Not-So-Dry July, is a testament to this, using humor to break down the stigma around vaginal dryness and encourage open conversations.
Looking ahead, Biolae's next frontier is the pharmacy. The author believes that entering this space is not just about earning shelf space but about reshaping how retailers think about menopause and the role these products play in women's lives. They also reflect on the journey so far, acknowledging the setbacks, pivots, and moments of uncertainty that come with being a startup. However, they remain excited about the future, as women's health finally receives the attention it deserves, with many unmet needs waiting to be solved.
